A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025
Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025
Manganese Accumulation in the Brain
NEJM 389:1320, Sherman,S.V., 2023
Clinicopathologic Conference, Anti-IgLON5 IgG-Associated Neurologic Disorder
NEJM 386:173-180, Case 1-2022, 2022
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
A Child with Arthrogryposis
Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018
A Child with Delayed Motor Milestones and Ptosis
Neurol 88:e158-e163, Ghosh, P.S., 2017
Identifying and Managing Common Childhood Language and Speech Impairments
BMJ 350:h2318, Reilly, S.,et al, 2015
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Botulism
Adams & Victors Principles of Neurology Chp 43, pg 1218, Ropper, A.H.,et al, 2014
A 62-Yeal-Old Man with Fluctuating Neurological Deficits and Skin Lesions
JAMA Neurol 70:120-124, Konikkara, J.,et al, 2013
Clinical Reasoning: A 13-year-old Boy Presenting with Dystonia,Myoclonus,and Anxiety
Neurol 78:e72-e76, Blackburn,J.S. and Cirillo,M.L., 2012
Clinicopathologic Conference, Villaret Syndrome (Ipsilateral Cranial Nerves and Cervical Sympathetic Fibers) due to a Carotid-Artery Dissection and an Associated Aneurysm
NEJM 366:2306-2313, Case 18-2012, 2012
Myasthenia Gravis
BMJ 345:e8497, Spillane, J.,et al, 2012
Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008
Botulinum Toxin Type A for Treating Voice Tremor
Arch Neurol 61:1416-1420, Adler,C.H.,et al, 2004
Polymyositis Masquerading as Motor Neuron Disease
Arch Neurol 60:1001-1003, Ryan,A.,et al, 2003
Botulinum Toxin as a Biological Weapon
JAMA 285:1059-1070, Arnon,S.S.,et al, 2001
Adult-Onset "Infant" Botulism:An Unusual Cause of Weakness in the Intensive Care Unit
Neurol 53:891, Li,L.Y.J.,et al, 1999
Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999
Reduction in Voice Tremor Under Thalamic Stimulation
Neurol 50:796-798, Carpenter,M.A.,et al, 1998
Management of Acoustic Neuroma
BMJ 311:1141-1144, Wright,A.&Bradford,R., 1995
Stridor and Focal Laryngeal Dystonia
Lancet 339:457-458, Marion,M.,et al, 1992
Spontaneous Rupture of the Common Carotid Artery:A Case Report
Head & Neck 14:496-501992., Kim,K.H.,et al, 1992
Essential Tremor:Clinical Correlates in 350 Patients
Neurol 41:234-238, Lou,J.&Jankovic,J., 1991
Classification and Treatment of Tremor
JAMA 266:1115-1117, Hallett,M., 1991
Therapeutic Uses Of Botulinum Toxin
NEJM 324:1186-1194, Jankovic,J.&Brin,M.F., 1991
Sarcoidosis of the Nervous System, A Clinical Approach
Arch Int Med 151:1317-1321, Sharma,Om.P.&Sharma,A.D., 1991
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Treatment of Speech and Voice Disorders with Botulinum Toxin
JAMA 264:2671-2675, Ludlow,C.L., 1990
Jugular Foramen Neuromas:A Review of 14 Cases
Surg Neurol 34:205-211, Tan,L.C.,et al, 1990
Effects of Botulinum Toxin Injections on Speech in Adductor Spasmodic Dysphonia
Neurol 38:1220-1225, Ludlow,C.L.,et al, 1988
Blepharospasm & Orofacial-Cervical Dystonia:Clinical & Pharmacological Findings in 100 Patients
Ann Neurol 13:402-411, Jankovic,J.,et al, 1983
Isaac Syndrome with Laryngeal Involvement:An Unusual Presentation of Myokymia
Neurol 29:1612-1615, Jackson,D.L.,et al, 1979
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974